Pharmaceutical propellant market leader Mexichem has announced its acquisition of a distribution and sale license for DuPont’s pharmaceutical grade Dymel 227ea/P propellant and says that it will market the product under its Zephex brand. Zephex propellants are used in about three quarters of all metered dose inhalers manufactured worldwide.
The acquisition of DuPont’s HFA-134a pharmaceutical grade propellant by India’s SRF conglomerate was announced earlier this month.
Mexichem Fluor Medical Products General Manager Simon Gardner commented, “Since 1995 Zephex products have filled around 3.5 billion inhalers, helping to improve the lives of over 100 million people every year. This acquisition highlights our continued commitment to leading the market and will allow us to further support a valuable part of our customer’s product portfolios.”
